Published in Circ Res on September 17, 1999
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov (2006) 2.84
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest (2006) 2.52
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther (2009) 1.66
Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats. Am J Hypertens (2009) 1.48
Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem (2009) 1.27
Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol (2001) 1.13
Estrogen, aging and the cardiovascular system. Future Cardiol (2009) 1.09
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation. Br J Pharmacol (2009) 1.06
Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats. Br J Pharmacol (2001) 1.05
Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci U S A (2004) 1.03
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease. Heart (2005) 1.01
Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front Physiol (2013) 0.98
Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology (2008) 0.98
Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species. Br J Pharmacol (2007) 0.98
Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity. J Biol Chem (2008) 0.97
Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction. Int J Mol Sci (2015) 0.96
Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat. J Pharmacol Exp Ther (2011) 0.91
Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice. Am J Pathol (2005) 0.91
Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR. Am J Physiol Lung Cell Mol Physiol (2009) 0.90
Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. Am J Physiol Heart Circ Physiol (2012) 0.89
RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase. Nitric Oxide (2011) 0.86
Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway. PLoS One (2012) 0.85
Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor. J Biol Chem (2008) 0.85
Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide. J Biol Chem (2012) 0.84
Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells. PLoS One (2011) 0.83
Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness. J Physiol (2016) 0.81
Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significance. Cardiovasc Res (2012) 0.81
Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase. Br J Pharmacol (2008) 0.80
Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm. Am J Physiol Heart Circ Physiol (2014) 0.79
Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats. Nitric Oxide (2013) 0.77
Promoter activity of the 5'-flanking regions of medaka fish soluble guanylate cyclase alpha1 and beta1 subunit genes. Biochem J (2002) 0.76
Reduction in blood pressure improves impaired nitroglycerine-induced vasodilation in patients with essential hypertension. Hypertens Res (2015) 0.75
Guanosine 3': 5'-cyclic monophosphate-dependent pathway alterations in ventricular cardiomyocytes of spontaneously hypertensive rats. Br J Pharmacol (2001) 0.75
Nitroxyl donors retain their depressor effects in hypertension. Am J Physiol Heart Circ Physiol (2013) 0.75
The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies. Br J Pharmacol (2015) 0.75
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 4.50
Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol (1991) 3.60
Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1991) 3.15
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol (1991) 2.72
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol (1991) 2.34
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett (1993) 2.14
Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A (1992) 1.93
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension (2001) 1.84
A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J (1992) 1.81
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun (1990) 1.61
Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med (2001) 1.60
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension (1994) 1.56
Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation (1996) 1.55
Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem (2000) 1.55
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res (1995) 1.51
Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem (1992) 1.50
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol (1999) 1.47
The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol (1999) 1.42
Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol (1990) 1.41
Colocalization of nitric oxide synthase and NADPH-diaphorase in the myenteric plexus of the rat gut. Neurosci Lett (1992) 1.40
Subpopulations of GABAergic neurons in laminae I-III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience (1994) 1.36
Complement activation by recombinant adenoviruses. Gene Ther (2001) 1.31
Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension (1997) 1.26
Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol Pharmacol (2008) 1.24
Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience (1993) 1.18
Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem J (1998) 1.16
Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. J Biol Chem (1999) 1.16
Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol (1990) 1.15
Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol (1997) 1.13
Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemia. Br J Pharmacol (1993) 1.11
Substance P and nitric oxide signaling in cerebral cortex: anatomical evidence for reciprocal signaling between two classes of interneurons. J Comp Neurol (2001) 1.09
Tetrahydrobiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase. J Biol Chem (1999) 1.07
Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation. Biochem Biophys Res Commun (1991) 1.06
Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney. J Am Soc Nephrol (1994) 1.02
Functional coupling of a Ca2+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J (1994) 1.01
Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol (1999) 1.00
Nitric oxide synthase and GABA colocalize in lamina II of rat spinal cord. Neurosci Lett (1992) 1.00
Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Hepatogastroenterology (1999) 0.99
Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol (1993) 0.99
Neurons in rat cerebral cortex that synthesize nitric oxide: NADPH diaphorase histochemistry, NOS immunocytochemistry, and colocalization with GABA. Neurosci Lett (1993) 0.98
Local modulation of noradrenaline release in vivo: presynaptic beta 2-adrenoceptors and endogenous adrenaline. J Cardiovasc Pharmacol (1984) 0.98
Thiol dependence of nitric oxide synthase. Biochemistry (1995) 0.98
Titer determination of Ad5 in blood: a cautionary note. Gene Ther (2003) 0.98
Characterization and localization of nitric oxide synthase in non-adrenergic non-cholinergic nerves from bovine retractor penis muscles. Br J Pharmacol (1992) 0.94
Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner. Free Radic Biol Med (2001) 0.94
Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol (1986) 0.93
Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. Klin Wochenschr (1986) 0.93
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol (1985) 0.93
Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail (1997) 0.93
Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther (1994) 0.92
Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn's disease. Eur J Clin Pharmacol (2007) 0.92
Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med (2000) 0.92
The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens Suppl (1993) 0.92
Colocalization of nitric oxide synthase and NADPH-diaphorase in cultured myenteric neurones. Neuroreport (1992) 0.92
Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-beta. Eur J Pharmacol (1992) 0.91
The vasopeptidase inhibitor AVE7688 ameliorates Type 2 diabetic nephropathy. Diabetologia (2003) 0.91
Apolipoprotein A-I induced amyloidosis. FEBS Lett (1998) 0.91
Muscle and nerve pathology in Dunnigan familial partial lipodystrophy. Neurology (2007) 0.91
Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. J Am Soc Nephrol (2001) 0.90
Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide. Biochem J (2000) 0.90
Endothelial protection by converting enzyme inhibitors. Cardiovasc Res (1994) 0.90
Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience (1998) 0.90
Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation (2000) 0.90
Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. Mol Pharmacol (1992) 0.90
Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system. Z Kardiol (1989) 0.90
Effects of Na+/H+ exchange inhibitors in cardiac ischemia. J Mol Cell Cardiol (1992) 0.89
Nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in a subpopulation of intrinsic neurones of the guinea-pig heart. Neurosci Lett (1992) 0.89
Autoinhibition of neuronal nitric oxide synthase: distinct effects of reactive nitrogen and oxygen species on enzyme activity. Biochem J (1999) 0.89
Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. J Hypertens Suppl (1988) 0.89
Electron-paramagnetic resonance spectroscopy using N-methyl-D-glucamine dithiocarbamate iron cannot discriminate between nitric oxide and nitroxyl: implications for the detection of reaction products for nitric oxide synthase. Free Radic Biol Med (2000) 0.89
Nitric oxide nerves in the uterus are parasympathetic, sensory, and contain neuropeptides. Cell Tissue Res (1995) 0.88
Decreased nitric oxide availability in normotensive and hypertensive rats with failing hearts after myocardial infarction. Hypertension (2001) 0.87
Anti-pterins as tools to characterize the function of tetrahydrobiopterin in NO synthase. J Biol Chem (1998) 0.87
Expression of nitric oxide synthase immunoreactivity by interstitial cells of the canine proximal colon. J Auton Nerv Syst (1994) 0.87
Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors? Basic Res Cardiol (1992) 0.87
Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. J Am Coll Cardiol (1999) 0.87
Neurons in rat hippocampus that synthesize nitric oxide. J Comp Neurol (1993) 0.86
Interactions of endothelins and EDRF in bovine native endothelial cells: selective effects of endothelin-3. Am J Physiol (1992) 0.86
Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor. J Med Chem (1999) 0.86
Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res (1994) 0.86
Synaptic interactions between primary afferent terminals and GABA and nitric oxide-synthesizing neurons in superficial laminae of the rat spinal cord. J Neurosci (1995) 0.86
Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain. Brain Res (2001) 0.85
Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction. Clin Exp Hypertens (2000) 0.85
Induction and variants of neuronal nitric oxide synthase type I during synaptogenesis. FASEB J (1995) 0.85
Intracardiac generation of angiotensin and its physiologic role. Circulation (1988) 0.85
Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol (1991) 0.85
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension (1992) 0.84
Just say NO to cancer? J Natl Cancer Inst (1997) 0.84
Cloning and functional expression of the calmodulin gene from Toxoplasma gondii. Mol Biochem Parasitol (1999) 0.84
Nitric oxide synthase expression reveals compartments of cerebellar granule cells and suggests a role for mossy fibers in their development. Neuroscience (1994) 0.83
Multiple mechanisms are involved in the acute vasodilatory effect of 17beta-estradiol in the isolated perfused rat heart. J Cardiovasc Pharmacol (1999) 0.83
Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension. J Cardiovasc Pharmacol (1998) 0.82
Liver cirrhosis in erythropoietic protoporphyria: improvement of liver function with ursodeoxycholic acid. Am J Gastroenterol (2001) 0.82
Effect of long-term ACE inhibition on myocardial tissue in hypertensive stroke-prone rats. J Mol Cell Cardiol (1999) 0.82
Kinins and cardioprotection. Pharmacol Res (1997) 0.82
MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13). Genes Chromosomes Cancer (2005) 0.82